Publications
Publications
Development of molecules for efficient genome transgenesis
Chromatin and epigenetic basis of stemness
Genome-engineered chicken/PGCs
•
Rezazade Bazaz M, Ghahramani Seno MM, Dehghani H. Transposase-CRISPR mediated
targeted integration (TransCRISTI) in the human genome. Sci Rep. 2022 Mar 1;12(1):3390.
•
Goshayeshi L, Yousefi Taemeh S, Dehdilani N, Nasiri M, Ghahramani Seno MM, Dehghani
H. CRISPR/dCas9-mediated transposition with specificity and efficiency of site-directed
genomic insertions. FASEB J. 2021 Feb;35(2):e21359. doi: 10.1096/fj.202001830RR.
•
Zare K, Shademan M, Ghahramani Seno MM, Dehghani H. CRISPR/Cas9 Knockout
Strategies to Ablate CCAT1 lncRNA Gene in Cancer Cells. Biol Proced Online. 2018;20:21.
doi: 10.1186/s12575-018-0086-5. eCollection 2018.
•
Dehghani H. Regulation of Chromatin Organization in Cell Stemness: The Emerging Role
of Long Non-coding RNAs. Stem Cell Rev Rep. 2021
•
Shademan M, Zare K, Zahedi M, Mosannen Mozaffari H, Bagheri Hosseini H,
Ghaffarzadegan K, Goshayeshi L, Dehghani H. Promoter methylation, transcription, and
retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas. Cancer Cell
Int. 2020;20:426. doi: 10.1186/s12935-020-01511-5. eCollection 2020.
•
Soltanian S, Dehghani H. BORIS: a key regulator of cancer stemness. Cancer Cell Int.
2018;18:154. doi: 10.1186/s12935-018-0650-8. eCollection 2018. Review.
•
Es-Haghi M, Soltanian S, Dehghani H. Perspective: Cooperation of Nanog, NF-κΒ, and
CXCR4 in a regulatory network for directed migration of cancer stem cells. Tumour Biol.
2016 Feb;37(2):1559-65. doi: 10.1007/s13277-015-4690-6.
•
Fussner E, Ahmed K, Dehghani H, Strauss M, Bazett-Jones DP. Changes in chromatin fiber
density as a marker for pluripotency. Cold Spring Harb Symp Quant Biol. 2010;75:245-9.
doi: 10.1101/sqb.2010.75.012.
•
Ahmed K, Dehghani H, Rugg-Gunn P, Fussner E, Rossant J, Bazett-Jones DP. Global
chromatin architecture reflects pluripotency and lineage commitment in the early mouse
embryo. PLoS One. 2010 May 7;5(5):e10531. doi: 10.1371/journal.pone.0010531.
•
Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, Bazett-Jones DP, Le
Grice S, McKay RD, Buetow KH, Gingeras TR, Misteli T, Meshorer E. Global transcription in
pluripotent embryonic stem cells. Cell Stem Cell. 2008 May 8;2(5):437-47. doi:
10.1016/j.stem.2008.03.021.
•
Dehghani H, Dellaire G, Bazett-Jones DP. Organization of chromatin in the interphase
mammalian cell. Micron. 2005;36(2):95-108. doi: 10.1016/j.micron.2004.10.003.
© Dr. Hesam Dehghani 2023
•
Dehdilani N, Yousefi Taemeh S, Rival Gervier S, Montillet G, Kress C, Jean C,
Goshayeshi L, Dehghani H. Pain B. Enhanced Cultivation of Chicken Primordial
Germ Cells. Sci Rep. 2023 In print.
•
Yousefi Taemeh S, Dehdilani N, Goshayeshi L, Rival-Gervier S, Mehrzad J, Pain B,
Dehghani H. Study of the regulatory elements of the Ovalbumin gene promoter
using CRISPR technology in chicken cells. J Biol Eng. 2023 Jul 17;17(1):46.
•
Dehdilani N, Goshayeshi L, Yousefi Taemeh S, Bahrami AR, Rival Gervier S, Pain B,
Dehghani H. Integrating Omics and CRISPR Technology for Identification and
Verification of Genomic Safe Harbor Loci in the Chicken Genome. Biol Proced
Online. 2023 Jun 24;25(1):18.
•
Dehdilani N, Yousefi Taemeh S, Goshayeshi L, Dehghani H. Genetically engineered
birds; pre-CRISPR and CRISPR era. Biol Reprod. 2022 Jan 13;106(1):24-46.
Novel vaccines and molecular diagnostics
•
Soleymani S, Tavassoli A, Hashemi Tabar G, Kalidari GA, Dehghani H. Design,
development, and evaluation of the efficacy of a nucleic acid-free version of a
bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80
serotype. Vet Res. 2020 Dec 9;51(1):144. doi: 10.1186/s13567-020-00867-w.
•
Tavassoli A, Soleymani S, Haghparast A, Hashemi Tabar G, Bassami MR, Dehghani
H. Reverse Genetics Assembly of Newcastle Disease Virus Genome Template
Using Asis-Sal-Pac BioBrick Strategy. Biol Proced Online. 2020;22:9. doi:
10.1186/s12575-020-00119-3. eCollection 2020.
•
Tabatabaeizadeh SE, Bassami MR, Haghparast A, Dehghani H. Employing XIAP to
enhance the duration of antigen expression and immunity against an avian
influenza H5 DNA vaccine. Immunol Invest. 2015;44(3):199-215. doi:
10.3109/08820139.2014.988718.
© Dr. Hesam Dehghani 2023